Supported funding for biomedical research at NIH has long been a bicameral, bipartisan priority.
Shelley Capito
The Public Record
Supported funding for biomedical research at NIH has long been a bicameral, bipartisan priority.
I would agree now is not the time for us to take the foot off the pedal when we're starting to see these early breakthroughs that affect so many families across the country.
Supported funding for biomedical research at NIH has long been a bicameral, bipartisan priority.
I want to ask you about the flat funding in Alzheimer's which makes absolutely no sense to me when we see the raging numbers.
I really want to thank you and Senator Reed for the initial passage of the Star Act and its reauthorization this year.
I know we're dealing with a tight budget year this year, but investments in biomedical research are so important for the future of our country.
There will be, and like if we look at like Dr. Volkow's area of expertise, it was thought initially, oh, well, if people can do telemedicine in this area with their-- and then you saw the numbers go up.
I think we've got to do a really deep down analysis, but I think where we really need to--and you all are doctors and thank goodness you are, but sometimes we need to communicate in plain language what is actually going on.





